Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.

BACKGROUND: Monotherapy for chronic hepatitis C using interferon (IFN) results in a very small proportion of patients exhibiting a sustained response. Clinical trials assessing the benefit of combination drug therapy may provide evidence of improved treatment response over that seen with single drug...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rasi, G, DiVirgilio, D, Mutchnick, M G, Colella, F, Sinibaldi-Vallebona, P, Pierimarchi, P, Valli, B, Garaci, E
Médium: Artigo
Jazyk:Inglês
Vydáno: 1996
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1383391/
https://ncbi.nlm.nih.gov/pubmed/9026482
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky